down arrow

Nanjing Well Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: CNE100003JD4
CNY
26.84
-2.19 (-7.54%)

Dec 04

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Nanjing Well Pharmaceutical Co., Ltd.
Why is Nanjing Well Pharmaceutical Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 10.61% and Operating profit at 6.30% over the last 5 years
2
Flat results in Mar 25
  • INTEREST COVERAGE RATIO(Q) Lowest at 1,523.98
  • DEBTORS TURNOVER RATIO(HY) Lowest at 5.04%
  • OPERATING PROFIT(Q) Lowest at CNY 44.52 MM
3
With ROE of 8.07%, it has a expensive valuation with a 2.07 Price to Book Value
  • Over the past year, while the stock has generated a return of 8.66%, its profits have risen by 12.1% ; the PEG ratio of the company is 2.1
  • At the current price, the company has a high dividend yield of 1.5
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals & Petrochemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Nanjing Well Pharmaceutical Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Nanjing Well Pharmaceutical Co., Ltd.
8.66%
0.73
40.71%
China Shanghai Composite
14.77%
1.01
14.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
10.61%
EBIT Growth (5y)
6.30%
EBIT to Interest (avg)
13.70
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.57
Tax Ratio
15.38%
Dividend Payout Ratio
37.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.61%
ROE (avg)
7.02%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.07
EV to EBIT
23.23
EV to EBITDA
12.94
EV to Capital Employed
1.92
EV to Sales
3.01
PEG Ratio
2.11
Dividend Yield
1.52%
ROCE (Latest)
8.25%
ROE (Latest)
8.07%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 214.62 MM

DEBT-EQUITY RATIO (HY)

Lowest at 15.24 %

RAW MATERIAL COST(Y)

Fallen by -8.91% (YoY

NET PROFIT(Q)

Highest at CNY 36.59 MM

-5What is not working for the Company
INTEREST COVERAGE RATIO(Q)

Lowest at 1,523.98

DEBTORS TURNOVER RATIO(HY)

Lowest at 5.04%

OPERATING PROFIT(Q)

Lowest at CNY 44.52 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 12.81 %

Here's what is working for Nanjing Well Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 214.62 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Debt-Equity Ratio
Lowest at 15.24 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Net Profit
Highest at CNY 36.59 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

Raw Material Cost
Fallen by -8.91% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Nanjing Well Pharmaceutical Co., Ltd.
Interest Coverage Ratio
Lowest at 1,523.98
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Operating Profit
Lowest at CNY 44.52 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 12.81 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Debtors Turnover Ratio
Lowest at 5.04%
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."